🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

As a #nonprofit Odylia focuses on the safety, efficacy, and available technologies for the therapeutics we develop. Our goal is to reach clinical trials in 2025. Join us, make a donation today. Link: shorturl.at/wF579

Consider donating to the #RPGRIP1 #GeneTherapy program before Sept 1 & your donation will be matched dollar-for-dollar. Your gift will help us reach our goal of raising $400,000 for the RPGRIP1 Program & clinical trials in 2025. odyliatherapeutics.salsalabs.org/rpgrip1campaig… #DontStopHope #visionloss

Odylia will be attending Global Genes 2023 RARE Patient Advocacy Summit & wants to meet with YOU! If you'd like to have a free 30min session with our scientists to discuss how we can help advance your therapeutic goals, please follow the link below. shorturl.at/aeqPR

Today is SATB2 Awareness Day. On June 22nd, the SATB2 Gene Foundation and Odylia Therapeutics presented at the SATB2 Research roundtable. We are in awe of the work they do to support people with SATB2-associated syndrome and their families. youtube.com/watch?v=yyfJJ0…

Thank you Greg Spitznagel for your support and good luck this season! Philadelphia Rebels NAHL #goalsforvision #RebelUp

Checkout Odylia’s CEO/CSO Ashley Winslow on Talking Biotech podcast this week!

Well done Greg Spitznagel !!!

When Big Pharma sees no market in treating rare disease, the non-profit Odylia Therapeutics seeks gene therapy solutions. My interview with CEO Dr. Ashley Winslow (who was an undergrad in my lab at UF IFAS Solutions ). This week's podcast. #MedTwitter share.transistor.fm/s/8236f127

🎧 Discover an incredible lineup of podcasts discussing #raredisease topics, all curated by DISORDER: The Rare Disease Film Festival. Tune in and explore the latest additions they've brought to their collection. Start listening now at bit.ly/3JT7nVE. 🧬 🦓

Check out this rare disease event, fundraising, and funding opportunity from The Orphan Disease Center @ UPenn #raredisease #drugdevelopment

BIG NEWS! We're thrilled to announce our strategic partnership with Odylia Therapeutics to advance patient-partnered drug development for RPGRIP1-Associated Retinal Dystrophy. 🧬🔬 #MedibanxOdyliaPartnership medibanx.com/the-latest/med…

We are proud to build and support ventures that are elevating their industry. Our portfolio company Medibanx is partnering with Odylia Therapeutics to develop gene therapy for vision loss. This is a noteworthy milestone in fostering patient engagement in drug development.

Philly and NJ folks join us for a somm-led wine tasting to support a good cause. We are teaming up with Sommsation to host a fabulous event. With wine and hope, anything is possible. sommsation.com/odylia #raredisease #nonprofit #nonprofitbiotech #winetasting #philadelphia

Go Philadelphia Rebels Go Greg Spitznagel !!!

Hey #Hockey fans! Check out rising star Greg Spitznagel of the Philadelphia Rebels. In addition to his hockey skills he supports our efforts to develop life changing treatments for rare vision loss disorders. If you are in the #Philadelphia area check out Greg & the Rebels!